Top

Published in:

01-05-2013 | Original Article

Peripheral blood gene expression signature differentiates children with autism from unaffected siblings

Authors: S. W. Kong, Y. Shimizu-Motohashi, M. G. Campbell, I. H. Lee, C. D. Collins, S. J. Brewster, I. A. Holm, L. Rappaport, I. S. Kohane, L. M. Kunkel

Published in: Neurogenetics | Issue 2/2013

Abstract

Autism spectrum disorder (ASD) is one of the most prevalent neurodevelopmental disorders with high heritability, yet a majority of genetic contribution to pathophysiology is not known. Siblings of individuals with ASD are at increased risk for ASD and autistic traits, but the genetic contribution for simplex families is estimated to be less when compared to multiplex families. To explore the genomic (dis-) similarity between proband and unaffected sibling in simplex families, we used genome-wide gene expression profiles of blood from 20 proband-unaffected sibling pairs and 18 unrelated control individuals. The global gene expression profiles of unaffected siblings were more similar to those from probands as they shared genetic and environmental background. A total of 189 genes were significantly differentially expressed between proband-sib pairs (nominal p < 0.01) after controlling for age, sex, and family effects. Probands and siblings were distinguished into two groups by cluster analysis with these genes. Overall, unaffected siblings were equally distant from the centroid of probands and from that of unrelated controls with the differentially expressed genes. Interestingly, five of 20 siblings had gene expression profiles that were more similar to unrelated controls than to their matched probands. In summary, we found a set of genes that distinguished probands from the unaffected siblings, and a subgroup of unaffected siblings who were more similar to probands. The pathways that characterized probands compared to siblings using peripheral blood gene expression profiles were the up-regulation of ribosomal, spliceosomal, and mitochondrial pathways, and the down-regulation of neuroreceptor-ligand, immune response and calcium signaling pathways. Further integrative study with structural genetic variations such as de novo mutations, rare variants, and copy number variations would clarify whether these transcriptomic changes are structural or environmental in origin.

Available only for authorised users

Luo R et al (2012) Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am J Hum Genet 91(1):38–55PubMed

Sanders SJ et al (2011) Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70:863–885PubMedCrossRef

Anney R et al (2010) A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 19(20):4072–82PubMedCrossRef

Alarcon M et al (2008) Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 82(1):150–9PubMedCrossRef

Hallmayer J et al (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68:1095–1102PubMedCrossRef

Ritvo ER et al (1989) The UCLA–University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 146(8):1032–6PubMed

Chakrabarti S, Fombonne E (2001) Pervasive developmental disorders in preschool children. JAMA 285(24):3093–9PubMedCrossRef

Ozonoff S et al (2011) Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 128(3):e488–95PubMed

Szatmari P et al (2000) The familial aggregation of the lesser variant in biological and nonbiological relatives of PDD probands: a family history study. J Child Psychol Psychiatry 41(5):579–86PubMedCrossRef

10.

Constantino JN et al (2006) Autistic social impairment in the siblings of children with pervasive developmental disorders. Am J Psychiatry 163(2):294–6PubMedCrossRef

11.

Losh M et al (2008) Defining key features of the broad autism phenotype: a comparison across parents of multiple- and single-incidence autism families. Am J Med Genet B Neuropsychiatr Genet 147B(4):424–33PubMedCrossRef

12.

Sebat J et al (2007) Strong association of de novo copy number mutations with autism. Science 316:445–449PubMedCrossRef

13.

Neale BM et al (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485:242–245PubMedCrossRef

14.

Pinto D et al (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466:368–372PubMedCrossRef

15.

Berg JM, Geschwind DH (2012) Autism genetics: searching for specificity and convergence. Genome Biol 13(7):247PubMedCrossRef

16.

Kong SW et al (2012) Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLoS One 7(12):e49475PubMedCrossRef

17.

Glatt SJ et al (2012) Blood-based gene expression signatures of infants and toddlers with autism. J Am Acad Child Adolesc Psychiatry 51(9):934–44 e2PubMedCrossRef

18.

Enstrom AM et al (2009) Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 23(1):124–33PubMedCrossRef

19.

Hu VW et al (2009) Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res 2(2):78–97PubMedCrossRef

20.

Hu VW et al (2009) Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One 4(6):e5775PubMedCrossRef

21.

Gregg JP et al (2008) Gene expression changes in children with autism. Genomics 91(1):22–9PubMedCrossRef

22.

Nishimura Y et al (2007) Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet 16(14):1682–98PubMedCrossRef

23.

Baron CA et al (2006) Utilization of lymphoblastoid cell lines as a system for the molecular modeling of autism. J Autism Dev Disord 36(8):973–82PubMedCrossRef

24.

Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100(16):9440–5PubMedCrossRef

25.

Schäfer J, Strimmer K (2005) A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics. Statist Appl Genet Mol Biol 4:(32)

26.

Reich M et al (2006) GenePattern 2.0. Nat Genet 38(5):500–1PubMedCrossRef

27.

Constantino JN et al (2010) Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry 167(11):1349–56PubMedCrossRef

28.

Kanehisa M et al (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40(Database issue):D109–14PubMedCrossRef

29.

Levy D et al (2011) Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70(5):886–97PubMedCrossRef

30.

Szatmari P et al (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319–328PubMedCrossRef

31.

Marshall CR et al (2008) Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82:477–488PubMedCrossRef

32.

Vargas DL et al (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57(1):67–81PubMedCrossRef

33.

Corbett BA et al (2007) A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry 12(3):292–306PubMed

34.

Garbett K et al (2008) Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30(3):303–11PubMedCrossRef

35.

Cross-Disorder Group of the Psychiatric Genomics, C. (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet

36.

Giulivi C et al (2010) Mitochondrial dysfunction in autism. JAMA 304(21):2389–96PubMedCrossRef

37.

Anitha A et al (2012) Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 23(3):294–302

38.

Chugani DC et al (1999) Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 23(4):635–41PubMedCrossRef

39.

Minshew NJ et al (1993) A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry 33(11–12):762–73PubMedCrossRef

Title: Peripheral blood gene expression signature differentiates children with autism from unaffected siblings
Authors: S. W. Kong
Y. Shimizu-Motohashi
M. G. Campbell
I. H. Lee
C. D. Collins
S. J. Brewster
I. A. Holm
L. Rappaport
I. S. Kohane
L. M. Kunkel
Publication date: 01-05-2013
Publisher: Springer-Verlag
Published in: Neurogenetics / Issue 2/2013
Print ISSN: 1364-6745
Electronic ISSN: 1364-6753
DOI: https://doi.org/10.1007/s10048-013-0363-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Peripheral blood gene expression signature differentiates children with autism from unaffected siblings

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways

Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland

Natural history of neurofibromatosis type 2 with onset before the age of 1 year

Novel TTC19 mutation in a family with severe psychiatric manifestations and complex III deficiency

Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery–Dreifuss muscular dystrophy plus phenotype

CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions